Archive for category: Latest Articles

A Randomized Trial on Clinical Outcomes and Stent Related Symptoms Following Intraureteral Stent on a String versus Conventional Stent Placement

Abstract

Introduction and objective

To minimize stent-related symptoms (SRS), a modified complete intra-ureteral stent with extraction suture was designed. The objective was to compare SRS of the conventional DJ stent and the complete intraureteral stent using the validated Ureteral Stent Symptom Questionnaire (USSQ).

Materials and Methods

We randomized 124 patients after uncomplicated ureteroscopic lithotripsy into complete intraureteral stent (CIUS) and conventional DJ stent (CUS) placement group. The USSQ scores were evaluated on postoperative day 1, day 7 (just before stent removal) and 4 weeks after stent removal (control values). Pain scores after stent removal were also recorded using visual analogue scale (VAS). Sub-domain analysis of all stent related symptoms and stent related complications were also compared.

Results

No significant intergroup differences were found in the domain scores of urinary symptoms (P = 0.74), pain (P = 0.32), general health (P = 0.27), work (P = 0.24), or additional problems (P = 0.29). However, statistically significant difference was noted on VAS scores (P = 0.015). Analysis of sub-domains of USSQ item scores revealed the CIUS group had significantly better scores for ‘‘urge incontinence’’ (1.21 vs. 1.00; p = <0.001), ‘‘discomfort on voiding’’ (2.07 vs. 1.50; p = <0.001), ‘‘difficulties with respect to light physical activity’’ (1.131 vs. 1.00; p = <0.001), ‘‘fatigue’’ (1.84 vs. 1.57; p = 0.002), “feeling comfortable” (3.68 vs. 3.16; p = 0.003), ‘‘need for extra help’’ (1.96 vs. 1.00; p = <0.001), and ‘‘change in duration of work’’(4.27 vs. 1.86; p = <0.001). However, the patients in the CIUS group were sexually inactive for the time till stent was indwelling (mean: 7.34 days). There was no difference in the complication rate between the 2 groups.

Conclusion

The use of complete intra ureteral stent placement with strings after URS decreases SRS.

How to evaluate a flexible ureterorenoscope? Systematic mapping of existing evaluation methods

Abstract

Introduction and objectives

Since the introduction of flexible ureterorenoscopes in the 1970’s, efforts have been made to reduce its size whilst optimizing the working channel for irrigation flow and introduction of accessory instruments. Meanwhile retaining optimal bidirectional deflecting properties and image quality. In an attempt to serve these seemingly conflicting interests, ureterorenoscopes have become more fragile. In this systematic scoping review we identified, mapped and reviewed scope-related and user-related parameters used to evaluate the quality of flexible ureterorenoscopes to identify key items and variability in grading systems.

Materials and methods

A literature search of four databases (MEDLINE (Ovid), Embase (Ovid), Web of Science, Google scholar and the Cochrane Library) was performed according to the PRISMA-guidelines enclosing articles published up to August 2020. A total of 2386 articles were screened.

Results

A total of 48 articles were included in this systematic scoping review. All studies had a prospective design. Five key items in the assessment of flexible URS were distinguished Maneuverability (87.5%), Optics (64.6%), Irrigation (56.3%), Handling (39.6%) and Durability (35.4%). After regrouping, every key item could be divided into specific subcategories. However, the quality-assessment showed a wide variation in denomination, method of measurement, circumstances of measurement, tools used during measurements, number of measurements performed, number of observers and units of outcomes.

Conclusion

The research field regarding quality assessment of ureterorenoscopes is heterogeneous. In this systematic scoping review we identified five key parameters: Maneuverability, Optics, Irrigation, Handling and Durability, used to grade flexible ureterorenoscopes. However, within these categories we found a wide variety in terms of method of measurements. A standardized, uniform grading tool is required to assess and compare the quality of flexible ureterorenoscopes in the future.

Safety and survival of docetaxel and cabazitaxel in metastatic castration‐resistant prostate cancer

Abstract

Introduction and objectives

Since the introduction of flexible ureterorenoscopes in the 1970’s, efforts have been made to reduce its size whilst optimizing the working channel for irrigation flow and introduction of accessory instruments. Meanwhile retaining optimal bidirectional deflecting properties and image quality. In an attempt to serve these seemingly conflicting interests, ureterorenoscopes have become more fragile. In this systematic scoping review we identified, mapped and reviewed scope-related and user-related parameters used to evaluate the quality of flexible ureterorenoscopes to identify key items and variability in grading systems.

Materials and methods

A literature search of four databases (MEDLINE (Ovid), Embase (Ovid), Web of Science, Google scholar and the Cochrane Library) was performed according to the PRISMA-guidelines enclosing articles published up to August 2020. A total of 2386 articles were screened.

Results

A total of 48 articles were included in this systematic scoping review. All studies had a prospective design. Five key items in the assessment of flexible URS were distinguished Maneuverability (87.5%), Optics (64.6%), Irrigation (56.3%), Handling (39.6%) and Durability (35.4%). After regrouping, every key item could be divided into specific subcategories. However, the quality-assessment showed a wide variation in denomination, method of measurement, circumstances of measurement, tools used during measurements, number of measurements performed, number of observers and units of outcomes.

Conclusion

The research field regarding quality assessment of ureterorenoscopes is heterogeneous. In this systematic scoping review we identified five key parameters: Maneuverability, Optics, Irrigation, Handling and Durability, used to grade flexible ureterorenoscopes. However, within these categories we found a wide variety in terms of method of measurements. A standardized, uniform grading tool is required to assess and compare the quality of flexible ureterorenoscopes in the future.

Definitive Radiotherapy for Extracranial Oligoprogressive Metastatic Renal Cell Carcinoma as a Strategy to Defer Systemic Therapy Escalation

Context

Prostate-specific antigen (PSA) testing increases prostate cancer diagnoses and reduces long-term disease-specific mortality, but also results in overdiagnoses and treatment-related harms.

Objective

To systematically assess the benefits and harms of population-based PSA screening and the potential net benefit to inform health policy decision-makers in Germany.

Evidence Acquisition

We performed a protocol-guided comprehensive literature search according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. All steps were performed by one or two investigators; any discrepancies were resolved by consensus. To allow subgroup analyses for identifying the optimal screening parameters, the eight national trials conducted under the umbrella of the European Randomised study of Screening for Prostate Cancer (ERSPC) were included as individual trials.

Evidence Synthesis

We included a total 11 randomised controlled trials (RCTs) with a total of 416 000 study participants. For all-cause mortality, we found neither benefit nor harm. PSA screening was associated with a reduced risk of both prostate cancer mortality and the development of metastases. For the outcomes of health-related quality of life, adverse effects and the consequences of false-negative screening results there was no difference; however, this was due to the lack of eligible RCT data. Finally, PSA screening was associated with large numbers of overdiagnoses with adverse downstream consequences of unnecessary treatment (e.g. incontinence, erectile dysfunction) and large numbers of false-positive PSA tests leading to biopsies associated with a small but not negligible risk of complications. Limitations of this assessment include the clinical heterogeneity and methodological limitations of the underlying studies.

Conclusions

The benefits of PSA-based prostate cancer screening do not outweigh its harms. We failed to identify eligible screening studies of newer biomarkers, PSA derivatives or modern imaging modalities, which may alter the balance of benefit to harm.

Patient Summary

In the present study, we reviewed the evidence on the PSA blood test to screen men without symptoms for prostate cancer. We found that the small benefits experienced by some men do not outweigh the harms to many more men.

The development of the C‐PAT: a concise tool to assess the quality of care in the cystectomy pathway

Objectives

To compare the functional outcomes of on- vs off-clamp robot-assisted partial nephrectomy (RAPN) within a randomized controlled trial (RCT).

Materials and Methods

The CLOCK study (CLamp vs Off Clamp the Kidney during robotic partial nephrectomy; NCT 02287987) is a multicentre RCT including patients with normal baseline function, two kidneys and masses with RENAL scores ≤ 10. Pre- and postoperative renal scintigraphy was prescribed. Renal defatting and hilum isolation were required in both study arms; in the on-clamp arm, ischaemia was imposed until the completion of medullary renorraphy, while in the off-clamp condition it was not allowed throughout the procedure. The primary endpoint was 6-month absolute variation in estimated glomerular filtration rate (AV-GFR); secondary endpoints were: 12, 18 and 24-month AV-GFR; 6-month estimated glomerular filtration rate variation >25% rate (RV-GFR >25); and absolute variation in ipsilateral split renal function (AV-SRF). The planned sample size was 102 + 102 cases, after taking account crossover of cases to the alternate study arm; a 1:1 randomization was performed. AV-GFR and AV-SRF were compared using analysis of covariation, and RV-GFR >25 was assessed using multivariable logistic regression. Intention-to-treat (ITT) and per-protocol analyses (PP) were performed.

Results

A total of 160 and 164 patients were randomly assigned to on- and off-clamp RAPN, respectively; crossover was observed in 14% and 43% of the on- and off-clamp arms, respectively. We were unable to find any statistically significant difference between on- vs off-clamp with regard to the primary endpoint (ITT: 6-month AV-GFR −6.2 vs −5.1 mL/min, mean difference 0.2 mL/min, 95% confidence interval [CI] −3.1 to 3.4 [P = 0.8]; PP: 6-month AV-GFR −6.8 vs −4.2 mL/min, mean difference 1.6 mL/min, 95% CI −2.3 to 5.5 [P = 0.7]) or with regard to the secondary endpoints. The median warm ischaemia time was 14 vs 15 min in the ITT analysis and 14 vs 0 min in the PP analysis.

Conclusion

In patients with regular baseline function and two kidneys, we found no evidence of differences in functional outcomes for on- vs off-clamp RAPN.

The BARCODE1 Pilot: a feasibility study of using germline SNPs to target prostate cancer screening

Abstract

Objectives

To assess the feasibility and uptake of a community based prostate cancer (PrCa) screening programme selecting men according to their genetic risk of PrCa.

To assess the uptake of PrCa screening investigations by men invited for screening.

The uptake of the pilot study would guide the opening of the larger BARCODE1 study recruiting 5000 men.

Subjects and Methods

Healthy males aged 55-69 years were invited to participate via their General Practitioners (GPs). Saliva samples were collected via mailed collection kits. After DNA extraction, genotyping was conducted using a study specific assay. Genetic risk was based on genotyping 130 germline PrCa risk single nucleotide polymorphisms (SNPs). A polygenic risk score (PRS) was calculated for each participant using the sum of weighted alleles for 130 SNPs. Study participants with a PRS lying above the 90th centile value were invited for PrCa screening by prostate MRI and biopsy.

Results

Invitation letters were sent to 1434 men. Overall study uptake was 26% (375/1436). 87% of responders were eligible for study entry. DNA genotyping data were available for 297. Twenty-five participants were invited for screening. After exclusions due to medical comorbidity/ invitations declined, 18 of 25 men (72%) underwent MRI and biopsy of the prostate. There were 7 diagnoses of PrCa (38.9%). All cancers were low-risk and were managed with Active Surveillance.

Conclusion

The BARCODE1 pilot has shown this community study in the UK to be feasible, with an overall uptake of 26%. The main BARCODE1 study is now open and will recruit 5,000 men. The results of BARCODE1 will be important in defining the role of genetic profiling in targeted PrCa population screening.

The association between modifiable perioperative parameters and renal function after nephrectomy

Abstract

Objectives

To evaluate the association between intraoperative anesthetic parameters, primarily intraoperative hypotension, and postoperative renal function in patients undergoing nephrectomy.

Patients and Methods

We reviewed data from 3,240 consecutive patients who underwent nephrectomy between 2010–2018. Anesthetic parameters evaluated included duration of hypotension, tachycardia, hypothermia, volatile anesthetic use and mean arterial pressure at the post-anesthesia care unit.

Outcomes included acute kidney injury (AKI) and estimated glomerular filtration rate (eGFR) within the first year after nephrectomy. Associations between anesthetic parameters and outcomes were evaluated with multivariable logistic regression and generalized estimating equation, respectively, adjusted for predictors of renal function after nephrectomy.

Results

Before nephrectomy, 677 (21%) patients had moderate-severe chronic kidney disease. A quarter of patients (n=809) had postoperative AKI and 35% (n=746) had stage ≥3 chronic kidney disease 12-months after surgery. Only 12% of patients (n=386) had >5 minutes of intraoperative hypotension. While not statistically significant, longer duration of intraoperative hypotension was associated with slightly higher rates of AKI (OR per 10-minutes 1.14; 95% CI 0.98, 1.32). Prolonged hypothermia was associated with increased rate of AKI (OR per 10-minutes 1.02; 95% CI 1.00, 1.04), and decreased eGFR (change in eGFR per 10-minutes -0.19; 95% CI -0.27, -0.12), however, these results have limited clinical significance.

Conclusions

Under current practice, intraoperative anesthetic parameters are tightly maintained, restricting the significance of their effect on postoperative renal function. Future studies should evaluate whether hemodynamic parameters during the early post-operative period, when they are monitored less frequently, are associated with renal functional outcome.

Causes and Prevention of Kidney Stones: Separating Myth from Fact

Abstract

Objectives

To evaluate the association between intraoperative anesthetic parameters, primarily intraoperative hypotension, and postoperative renal function in patients undergoing nephrectomy.

Patients and Methods

We reviewed data from 3,240 consecutive patients who underwent nephrectomy between 2010–2018. Anesthetic parameters evaluated included duration of hypotension, tachycardia, hypothermia, volatile anesthetic use and mean arterial pressure at the post-anesthesia care unit.

Outcomes included acute kidney injury (AKI) and estimated glomerular filtration rate (eGFR) within the first year after nephrectomy. Associations between anesthetic parameters and outcomes were evaluated with multivariable logistic regression and generalized estimating equation, respectively, adjusted for predictors of renal function after nephrectomy.

Results

Before nephrectomy, 677 (21%) patients had moderate-severe chronic kidney disease. A quarter of patients (n=809) had postoperative AKI and 35% (n=746) had stage ≥3 chronic kidney disease 12-months after surgery. Only 12% of patients (n=386) had >5 minutes of intraoperative hypotension. While not statistically significant, longer duration of intraoperative hypotension was associated with slightly higher rates of AKI (OR per 10-minutes 1.14; 95% CI 0.98, 1.32). Prolonged hypothermia was associated with increased rate of AKI (OR per 10-minutes 1.02; 95% CI 1.00, 1.04), and decreased eGFR (change in eGFR per 10-minutes -0.19; 95% CI -0.27, -0.12), however, these results have limited clinical significance.

Conclusions

Under current practice, intraoperative anesthetic parameters are tightly maintained, restricting the significance of their effect on postoperative renal function. Future studies should evaluate whether hemodynamic parameters during the early post-operative period, when they are monitored less frequently, are associated with renal functional outcome.

90‐day cause‐specific mortality after radical prostatectomy. Nationwide population‐based study

Abstract

Objectives

To evaluate the association between intraoperative anesthetic parameters, primarily intraoperative hypotension, and postoperative renal function in patients undergoing nephrectomy.

Patients and Methods

We reviewed data from 3,240 consecutive patients who underwent nephrectomy between 2010–2018. Anesthetic parameters evaluated included duration of hypotension, tachycardia, hypothermia, volatile anesthetic use and mean arterial pressure at the post-anesthesia care unit.

Outcomes included acute kidney injury (AKI) and estimated glomerular filtration rate (eGFR) within the first year after nephrectomy. Associations between anesthetic parameters and outcomes were evaluated with multivariable logistic regression and generalized estimating equation, respectively, adjusted for predictors of renal function after nephrectomy.

Results

Before nephrectomy, 677 (21%) patients had moderate-severe chronic kidney disease. A quarter of patients (n=809) had postoperative AKI and 35% (n=746) had stage ≥3 chronic kidney disease 12-months after surgery. Only 12% of patients (n=386) had >5 minutes of intraoperative hypotension. While not statistically significant, longer duration of intraoperative hypotension was associated with slightly higher rates of AKI (OR per 10-minutes 1.14; 95% CI 0.98, 1.32). Prolonged hypothermia was associated with increased rate of AKI (OR per 10-minutes 1.02; 95% CI 1.00, 1.04), and decreased eGFR (change in eGFR per 10-minutes -0.19; 95% CI -0.27, -0.12), however, these results have limited clinical significance.

Conclusions

Under current practice, intraoperative anesthetic parameters are tightly maintained, restricting the significance of their effect on postoperative renal function. Future studies should evaluate whether hemodynamic parameters during the early post-operative period, when they are monitored less frequently, are associated with renal functional outcome.

Circulating tumor DNA reveals genetic traits of patients with intraductal carcinoma of the prostate

Abstract

Objectives

To investigate the genetic alterations of prostate cancer (PCa) patients with and without intraductal carcinoma of the prostate (IDC-P).

Materials and Methods

We performed targeted sequencing of plasma cell-free DNA on 161 patients of prostate adenocarcinoma (PAC) with IDC-P and 84 cases without IDC-P. Genomic alterations were compared between these two groups. The association between genetic alterations and patients’ survival outcomes was also explored.

Results

Totally, we identified 29.8% (48/161) and 21.4% (18/84) patients with and without IDC-P harbored genomic alterations in DNA repair pathway, respectively (P=0.210). Pathogenic germline DNA repair alterations were frequently detected in IDC-P carriers compared to IDC-P non-carries (11.8% [19/161] vs. 2.4% [2/84], P=0.024). Germline BRCA2 and somatic CDK12 defects were specifically identified in IDC-P carriers relative to PAC (BRCA2: 8.7% [14/161] vs. 0% and CDK12: 6.8% [11/161] vs. 1.2% [1/84]). Patients with IDC-P had a distinct AR pathway alteration, characterized by an enrichment of NCOR2 mutations against patients with pure PAC (21.1% [34/161] vs. 6.0% [5/84], P=0.004). Increased AR alterations were detected in patients harbouring tumors with IDC-P proportion≥10% versus cohort with IDC-P proportion<10% (6.4% [5/78] vs. 18.1% [15/83], P=0.045). For IDC-P carries, TP53 mutation was associated with shorter castration-resistant free survival (median 10.9-Mo vs. 28.9-Mo, P=0.026), and BRCA2 alteration was related to rapid PSA progression for those receiving abiraterone treatment (median 9.1-Mo vs 11.9-Mo, P=0.036).

Conclusion

Our findings provide genomic evidence explaining the aggressive phenotype of tumors with IDC-P, highlighting the potential therapeutic strategies for this patient population.

© 2024 BJU International. All Rights Reserved.